Goldman Sachs Group Inc Teva Pharmaceutical Industries LTD Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
A detailed history of Goldman Sachs Group Inc transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Goldman Sachs Group Inc holds 4,158,328 shares of TEVA stock, worth $71.2 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,158,328
Previous 4,290,647
3.08%
Holding current value
$71.2 Million
Previous $69.7 Million
7.47%
% of portfolio
0.01%
Previous 0.01%
Shares
19 transactions
Others Institutions Holding TEVA
# of Institutions
624Shares Held
573MCall Options Held
19.6MPut Options Held
6.77M-
Black Rock Inc. New York, NY43MShares$736 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.2MShares$620 Million35.87% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L334.5MShares$591 Million5.5% of portfolio
-
Menora Mivtachim Holdings Ltd.28.8MShares$494 Million3.32% of portfolio
-
Exor Capital LLP London, X026.5MShares$454 Million14.79% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $19B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...